AllianceBernstein’s Genprex GNPX Stock Holding History

AllianceBernstein’s Portfolio GNPX Stock Details GNPX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-1	Closed	-$177K	–	3360
2021 Q1	$177K	Hold	1	–	–	﹤0.01%	3085
2020 Q4	$170K	Hold	1	–	–	﹤0.01%	3031
2020 Q3	$138K	Hold	1	–	–	﹤0.01%	3023
2020 Q2	$129K	Buy	+1	New	+$122K	﹤0.01%	3073

Other funds holding GNPX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Ergoteles New York $68.2M AUM 36.16% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

AllianceBernstein's GNPX Position: Q2 2021 in Review

AllianceBernstein sold out of Genprex (GNPX) in Q2 2021, closing a stake of 1 share — an estimated $177K sold.

AllianceBernstein first reported a position in GNPX in Q2 2020 and held it in 4 quarters. The position peaked at $177K in Q1 2021. 32 funds tracked by Wall St. Rank hold GNPX as of Q2 2021.

AllianceBernstein reported no remaining Genprex position as of Q2 2021 after selling out during the quarter.
AllianceBernstein sold 1 Genprex share in Q2 2021, an estimated $177K.
AllianceBernstein first reported a position in Genprex in Q2 2020 and held it in 4 quarters.
AllianceBernstein's Genprex position peaked at $177K in Q1 2021.
32 funds tracked by Wall St. Rank held Genprex as of Q2 2021.

Based on AllianceBernstein's 13F filing for Q2 2021, filed 30 Jul 2021.